From Casetext: Smarter Legal Research

Enzon Pharms., Inc. v. Nektar Therapeutics

Appellate Division of the Supreme Court of the State of New York
Feb 2, 2017
2017 N.Y. Slip Op. 63292 (N.Y. App. Div. 2017)

Opinion

Motion No: M-6046

02-02-2017

Enzon Pharmaceuticals, Inc., (formerly known as Enzon, Inc.), Plaintiff-Appellant, v. Nektar Therapeutics (formerly known as Inhale Therapeutic Systems, Inc.), Defendant-Respondent.


Defendant-respondent having moved for clarification/ reargument of, or in the alternative, for leave to appeal to the Court of Appeals, from the decision and order of this Court, entered on October 25, 2016 (Appeal No. 2040), Now, upon reading and filing the papers with respect to the motion, and due deliberation having been had thereon, It is ordered that the motion is denied.

ENTERED: February 2, 2017

_____________________ CLERK

PRESENT: Hon. Rolando T. Acosta,Justice Presiding, Dianne T. Renwick David B. Saxe Paul G. Feinman Marcy L. Kahn,Justices

M-6046

Index No. 652283/15


Summaries of

Enzon Pharms., Inc. v. Nektar Therapeutics

Appellate Division of the Supreme Court of the State of New York
Feb 2, 2017
2017 N.Y. Slip Op. 63292 (N.Y. App. Div. 2017)
Case details for

Enzon Pharms., Inc. v. Nektar Therapeutics

Case Details

Full title:Enzon Pharmaceuticals, Inc., (formerly known as Enzon, Inc.)…

Court:Appellate Division of the Supreme Court of the State of New York

Date published: Feb 2, 2017

Citations

2017 N.Y. Slip Op. 63292 (N.Y. App. Div. 2017)